- No file added yet -

Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

figure

posted on 2020-09-23, 10:18 authored by Hoda Taheri, Mojtaba Malek, Faramarz Ismail-Beigi, Farhad Zamani, Masoudreza Sohrabi, Mohammad Reza babaei, Mohammad E. Khamseh

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).